MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
LivaNova PLC Net Debt 2011-2026 | LIVN
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt LivaNova PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -282 M | 130 M | 310 M | 11.8 M | -187 M | 401 M | 272 M | 121 M | 52.4 M | 56.7 M | -124 M | -103 M | -121 M | -96.7 M | -82.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 401 M | -282 M | 24 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.64 B | $ 13.27 | -1.35 % | $ 1.79 B | USA |
 |
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-16.3 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
6.1 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-230 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-22.8 M | $ 3.3 | -0.15 % | $ 124 M |  France |
 |
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
-10.5 M | $ 25.74 | - | $ 218 M | USA |
 |
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
11 M | $ 0.64 | 6.67 % | $ 39.8 M | USA |
 |
ClearPoint Neuro
CLPT
|
3.85 M | $ 10.74 | -3.07 % | $ 304 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.8 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
-511 M | $ 89.45 | -1.39 % | $ 12.1 B | USA |
 |
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
230 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
2.62 M | - | -0.97 % | $ 54.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
-5.12 M | $ 2.07 | -0.48 % | $ 1.26 M | USA |
 |
GBS
GBS
|
-4.38 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-2.3 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-4.95 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-65.9 M | $ 5.07 | -1.65 % | $ 1.07 B | USA |
 |
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | USA |
 |
Pulmonx Corporation
LUNG
|
-31.6 M | $ 1.23 | 0.41 % | $ 50 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 14.87 | -1.78 % | $ 349 M | USA |
 |
Delcath Systems
DCTH
|
-42.5 M | $ 10.31 | -2.27 % | $ 369 M | USA |
 |
Orthofix Medical
OFIX
|
78.5 M | $ 11.62 | -2.43 % | $ 460 M |  Curacao |
 |
IRIDEX Corporation
IRIX
|
-5.23 M | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
Insulet Corporation
PODD
|
468 M | $ 180.5 | -1.3 % | $ 12.7 B | USA |
 |
CONMED Corporation
CNMD
|
802 M | $ 36.61 | -0.49 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
-433 M | $ 54.6 | -0.9 % | $ 1.6 B | USA |
 |
LENSAR
LNSR
|
-10.2 M | $ 5.29 | -1.12 % | $ 63.3 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.18 B | $ 83.71 | -1.1 % | $ 2.91 B | USA |
 |
Invacare Corporation
IVC
|
299 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
-2.32 B | $ 81.55 | -0.89 % | $ 47.7 B | USA |
 |
Sintx Technologies
SINT
|
-898 K | $ 2.13 | -0.7 % | $ 5.91 M | USA |
 |
Stryker Corporation
SYK
|
11 B | $ 315.23 | -1.95 % | $ 120 B | USA |
 |
MiMedx Group
MDXG
|
-148 M | $ 3.37 | -0.88 % | $ 498 M | USA |
 |
Tactile Systems Technology
TCMD
|
-75.4 M | $ 22.99 | -2.46 % | $ 526 M | USA |
 |
TELA Bio
TELA
|
5.33 M | $ 0.77 | -1.28 % | $ 36.1 M | USA |